Heather Parsons

22PUBLICATIONS
201CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursHaematological tumoursCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 13, 2026
Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2- Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I Trial.

|Mar 10, 2026
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.

Natasha B Hunter, Heather A Parsons, Leslie Cope

|Mar 04, 2026
A glucocorticoid-FAS axis controls immune evasion during metastatic seeding.

Monica Cassandras, Xavier Sanchez, Lauren Hsu

|Sep 15, 2025
Clonal Hematopoiesis Dynamics and Evolutionary Fitness During Cancer Treatment Impact Clinical Outcomes.

Mona Arabzadeh, Yi-Han Tang, Christelle Colin-Leitzinger

|Apr 10, 2025
Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer.

Panagiotis A Konstantinopoulos, Mingyang Cai, Elizabeth K Lee

|Jan 17, 2025
Clonal Hematopoiesis in Women With Breast Cancer.

Christina Mayerhofer, Rachel A Freedman, Heather A Parsons

Pageof 4

Frequent Collaborators

9 joint publications

Sara M Tolaney

5 joint publications

Viktor A Adalsteinsson

5 joint publications

Daniel G Stover

4 joint publications

Ann Partridge